期刊文献+

阿尔茨海默病的Aβ级联机制研究进展 被引量:4

Research Progress of AβCascade in Alzheimer’s Disease
下载PDF
导出
摘要 阿尔茨海默病(Alzheimer’s disease,AD)是一种慢性进展性神经系统退行性疾病,β-淀粉样蛋白(amyloidβ-protein,Aβ)沉积所形成的老年斑是其主要病理特征之一,而Aβ级联学说也成为目前较为公认、热点研究的AD发病机制之一。本文将从Aβ引发神经元凋亡、突触功能障碍、神经炎症及tau蛋白过磷酸化等方面,对AD的Aβ级联机制研究进展予以综述,为进一步集成化、整体性研究AD的Aβ级联机制提供支持。 Alzheimer’s disease(AD)is a chronic progressive neurodegenerative disease,and amyloidβ-protein(Aβ)deposit derived senile plaques(SPs)in the brain are one of the main pathological features.The Aβcascade theory has also become one of the most recognized hot topics in the study of AD pathogenesis.This paper reviews the research progress of Aβcascade in AD,including Aβ-induced neuronal apoptosis,synaptic dysfunction,neuroinflammation and tau protein hyperphosphorylation,etc,and may provide support for further integrated and holistic research on Aβcascade mechanism of AD.
作者 李明成 周君 米彩云 王虎平 LI Ming-cheng;ZHOU Jun;MI Cai-yun;WANG Hu-ping(Gansu University of Traditional Chinese Medicine,Lanzhou 730000,Gansu,China)
机构地区 甘肃中医药大学
出处 《生命科学研究》 CAS CSCD 2022年第5期406-412,432,共8页 Life Science Research
基金 国家自然科学基金资助项目(81960828) 甘肃省自然科学基金项目(20JR10RA319) 甘肃省高等学校创新能力提升项目(2019B-100)。
关键词 阿尔茨海默病(AD) Aβ级联学说 神经元凋亡 突触功能障碍 神经炎症 tau蛋白过磷酸化 Alzheimer’s disease(AD) Aβ cascade theory neuronal apoptosis synaptic dysfunction neuroinflammation tau protein hyperphosphorylation
  • 相关文献

参考文献6

二级参考文献46

  • 1冯利杰,王海萍,沈玉先.内质网应激与神经元退行性变[J].中国药理学通报,2007,23(4):428-432. 被引量:9
  • 2van der Kallen C J, van Greevenbroek M M, Stehouwer C D,Schalkwijk C G. Endoplasmic reticulum stress-induced apoptosis in the development of diabetes: is there a role for adipose tissue and liver[ J]. Apoptosis ,2009,14(12) : 1424 - 34.
  • 3Bitko V, Barik S. An endoplasmic reticulum-specific stress-activated caspase (caspase-12)is implicated in the apoptosis of A549 epithelial ceils by respiratory syncytial virus [ J ]. J Cell Biochem, 2001,80(3 ) :441 -54.
  • 4MOHANDAS E, RAJMOHAN V, RAGHUNATH B. Neurobiol- ogy of Alzheimer's disease[J]. Indian Journal of Psychiatry, 2009, 51(1): 55-61.
  • 5LEISSRING M A. The ACs of A-cleaving proteases[J]. Jour- nal of Biological Chemistry, 2008, 283(44): 29645-29649.
  • 6NAL1VAEVA N N, BECKETT C, BELYAEV N D, et al. Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease? [J]. Journal of Neurochemistry, 2012, 120 (Supplement 1): 167-185.
  • 7DEMATTOS R B, BALES K R, CUMMINS D J, et al. Periph- eral anti-A beta antibody alters CNS and plasma A beta clear- ance and decreases brain A beta burden in a mouse model of Alzheimer's disease[J]. Proceedings of the National Academy of Sciences of the United States of America, 2001, 98(15): 8850- 8855,.
  • 8PAN X D, ZHU Y G, LIN N, et al. Microglial phagocytosis in- duced by fibrillar beta-amyloid is attenuated by oligomeric be- ta-amyloid: implications for Alzheimer's disease[J]. MolecularNeurodegeneration, 2011, 6( 1 ): 45.
  • 9SOLITO E, SASTRE M. Microglia function in Alzheimer's dis- ease[J]. Frontiers in pharmacology, 2012, (3): 14.
  • 10MATOUSEK S B, GHOSH S, SHAFTEL S S, et al. Chronic IL- 1 beta-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer's disease without in- ducing overt neurodegeneration[J]. Journal of Neuroimmune Phar- macology: the Official Journal of the Society on Neurnlmmune Pharmacology, 2012, 7(1): 156-164.

共引文献69

同被引文献69

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部